MENLO PARK, Calif., June 15 /PRNewswire/ -- ForteBio, Inc., developer of label-free systems for real-time detection and analysis of molecular interactions, today announced the election of K. Peter Hirth, Ph.D., to its Board of Directors. Dr. Hirth is Co-Founder and Chief Executive Officer of Plexxikon, a biotechnology leader in the discovery and development of novel small molecule pharmaceuticals to treat human disease.
